جست‌وجوی استاد و پژوهشگر

Kishan Dholakiaمشاهده پروفایل

استاد

• Optical tweezers
• Biophotonics
• Laser beam manipulation
• +۹ مورد دیگر

Professor Kishan Dholakia is a distinguished academic at the University of St Andrews, holding positions at the School of Physics and Astronomy, Sir James Mackenzie Institute for Early Diagnosis, Centre for Biophotonics, Institute of Behavioural and Neural Sciences, and Biomedical Sciences Research Complex. With a career spanning decades, he has established himself as a leading researcher in optical physics and biophotonics. His research interests focus on the application of shaped laser beams to trap, analyze and manipulate colloidal particles, cells and tissue. His work encompasses optical tweezers and particle rotation with applications in biophotonics, studies of novel light beams (including Bessel beams, Airy beams, Laguerre-Gaussian beams), shaping light through disordered materials, advanced imaging, Raman analysis, and cell nanosurgery. His research has significant industrial relevance in single and multi-beam optical traps, drug delivery, gene therapy, cancer research, and Raman analysis. Professor Dholakia's recent publications demonstrate a consistent focus on advancing optical manipulation techniques, precision measurement, and imaging technologies. His work increasingly integrates machine learning with traditional optical methods, as seen in applications ranging from whisky identification to embryo development analysis. The research spans fundamental physics of light-matter interaction to practical biomedical applications. 2017 Thomas Young Medal and Prize 2018 SPIE Dennis Gabor Award Fellow of the Royal Society of Edinburgh (2007) Fellow of the Optical Society of America Fellow of SPIE EPSRC Public Understanding of Science Award (2004) Photonics Club of Excellence Prize USA (2005) Professor Dholakia is deeply committed to teaching and science communication, having instigated and delivered two lecture courses at St Andrews: "Biophotonics" and "Applications of Quantum Physics." He has also designed optical trapping systems for undergraduate and Masters course laboratories. His research is supported by numerous projects including European Commission grants (PROSCOPE, DynAMic) and EPSRC funding (TRAFIX, Prosperity Partnership). He leads research within the Centre for Biophotonics at St Andrews, where his group develops cutting-edge optical manipulation and imaging technologies, with strong connections to biomedical applications and commercial translation through various partnerships.

Jesús Lavado Garcíaمشاهده پروفایل

پژوهشگر

• Recombinant Adeno-associated Virus (rAAV) Production
• Virus-Like Particles (VLPs) Production
• Bioprocess Engineering
• +۳ مورد دیگر

Jesús Lavado García serves as Postdoctoral Researcher and Co-Principal Investigator at the Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain), Technical University of Denmark. His research focuses on advancing bioprocess engineering for viral vector manufacturing, particularly recombinant adeno-associated viruses (rAAVs) and virus-like particles (VLPs), with direct applications in gene therapy and vaccine development. His core research areas include: Overcoming the cell density effect in mammalian cell cultures Optimizing full-to-empty particle ratios in rAAV production Engineering heparan sulfate proteoglycan interactions for enhanced transfection Metabolic pathway modulation for increased vector yields Statistical design of experiments for bioprocess optimization Glycobiology applications in viral vector manufacturing Analysis of his 2022-2025 publications reveals concentrated innovation in rAAV/VLP process development, with emphasis on resolving production bottlenecks through cell engineering and bioprocess design. His work demonstrates particular expertise in leveraging DNA damage response pathways, extracellular vesicle dynamics, and metabolic engineering to enhance vector titers while maintaining quality attributes. Scientific awards: No awards identified in source materials. Dr. Lavado García actively mentors PhD candidates M. Rahimi (cell density effect engineering) and D. C. Tatjer (CHO-based rAAV processes). He serves as Principal Investigator for the Novo Nordisk Foundation-funded HEDGE-A project (2023-2026) targeting high-density rAAV manufacturing, and as Co-PI on multiple grants addressing viral vector production challenges through mammalian cell engineering approaches. He leads the Quantitative Modeling of Cell Metabolism group at DTU Biosustain, collaborating with European research networks to develop scalable platforms for next-generation gene therapy vectors, with current work focusing on translation of lab-scale optimizations to industrial biomanufacturing.

• Computer Communications
• Fluid Modeling
• Parallel Computing
• +۵ مورد دیگر

Miloš Ivanović serves as an Assistant Professor at the Institute of Mathematics and Informatics within the Faculty of Natural Sciences and Mathematics at the University of Kragujevac. His academic career is deeply rooted in computer science and computational mathematics, with research spanning multiple interdisciplinary domains that bridge theoretical computer science with practical applications in engineering, physics, and biology. Dr. Ivanović earned his Doctorate in Computer Science from the Faculty of Natural Sciences and Mathematics (PMF) at the University of Kragujevac, establishing a foundation for his subsequent research career focused on computational methods and high-performance computing. His research interests represent a sophisticated convergence of computational theory and practical applications. Ivanović specializes in advanced computing paradigms including grid computing, GPGPU computing, and cloud-based high-performance computing systems. His work in fluid modeling employs meshless methods and particle dynamics approaches, particularly SPH and DPD techniques applied to microfluidic systems. The breadth of his research extends from theoretical mathematics (graph theory and chemical indices) to practical applications in hydrology, biomedical engineering, and nuclear physics. His interdisciplinary approach enables innovative solutions across diverse scientific domains that require intensive computational resources. The collection of his publications reveals a consistent trajectory of research focused on computational methods with applications spanning multiple scientific disciplines. His work demonstrates strong expertise in parallel computing architectures and their application to complex scientific problems. The publications show a progression from fundamental computational mathematics toward increasingly complex multi-domain applications, particularly in biomedical and environmental systems. His research consistently addresses the challenge of implementing computationally intensive methods on distributed and parallel architectures to solve real-world scientific problems. Throughout his career, Ivanović has participated in numerous national and European research and infrastructure projects, including FP6, FP7, and Tempus initiatives. His collaborative approach is evident in the diverse range of co-authors spanning multiple institutions and disciplines, reflecting his ability to bridge computational science with domain-specific applications. Dr. Ivanović is affiliated with the Group for Mathematical Modeling and Computer Simulations, which develops computational solutions across various domains including fluid dynamics, biomedical applications, and environmental modeling. The group's work encompasses software development for simulation purposes, as evidenced by projects like the SPH07 software package and various specialized simulation tools for engineering and biomedical applications.

• Acoustics
• Microfluidics
• Ultrasonics
• +۶ مورد دیگر

Mikael Evander is a Researcher at Lund University's Department of Biomedical Engineering within the Faculty of Engineering, specializing in acoustofluidics. He is affiliated with the Acoustofluidics group and has published 52 research outputs across articles, conference proceedings, and book chapters. His work contributes to UN Sustainable Development Goals related to health and wellbeing. Evander's research spans acoustics engineering (100%), particle material science (58%), microfluidics (50%), transducer engineering (36%), and ultrasonics (34%). His work focuses on developing acoustic trapping technologies for biomedical applications, particularly in manipulating particles, cells, and extracellular vesicles. He has pioneered techniques for silica seed particles to improve nanoparticle acoustic trapping efficiency and throughput, as well as methods for rapid acoustic isolation of extracellular vesicles from blood plasma samples. His recent publications (2021-2024) demonstrate a clear trend toward clinical applications, especially in cancer diagnostics through exosome and microRNA analysis. The research shows increasing sophistication in acoustic trapping systems, moving from basic particle manipulation to complex biomedical sample processing for prostate cancer detection and proteome analysis. Best Poster Award (2023 Nov 17) for work on exosome proteome analysis Evander actively supervises graduate research, having mentored at least two students including C. Johannesson (Dissertation: Acoustic trapping, 2015-2019) and M. Isaksson (MoDeNT project). He is currently involved in four major projects with significant grant funding: AcouSome (exosome separation from blood, 2023-2025), MoDeNT (Model of the Developing Neural Tube), Sowing the seeds of acoustic trapping (2020-2025), and previously supervised the Acoustic trapping dissertation project. As a key member of the Acoustofluidics group, Evander collaborates extensively with Professor Thomas Laurell and Dr. Andreas Lenshof. His work bridges engineering and medical applications, with recent focus on translating acoustic trapping technology into clinical diagnostic tools for cancer detection and personalized medicine.

• Neurophysiology
• Neuropharmacology
• Mitochondrial Biology
• +۵ مورد دیگر

Dr. Andrew Paterson is a Senior Lecturer at the School of Health, Leeds Beckett University, with expertise in neurophysiology and neuropharmacology. He holds a BSc (Hons) in Biomedical Sciences (Pharmacology) from Aberdeen University and a PhD in mitochondrial physiology from the University of Edinburgh's Centre for Integrative Physiology. Current teaching responsibilities: Human Physiology, Medical Pathophysiology, Topics in Neuroscience, and Project modules for Biomedical Sciences undergraduates Teaches Molecular Cell Biology and Physiology for Biomedical Sciences MSc courses Contributes to Medical Science modules for Speech and Language Therapy and Nursing programs His research focuses on formyl peptide receptors (FPRs) in neurological disorders, nano-particle cytotoxicity for cancer applications, and antimicrobial phytochemicals . Recent work explores: Neurite outgrowth mechanisms via FPR agonists Targeted nanoparticle delivery systems Herbal compound cytotoxicity assessment Collaborating with Dr. Margarita Gomez Escalada, he investigates novel antimicrobials for antibiotic resistance solutions. His publications since 2006 address mitochondrial dysfunction in neurodegeneration, receptor signaling, and oxidative stress mechanisms. Contact: A.Paterson@leedsbeckett.ac.uk | Office: Portland 306, City Campus

Thor Grundtvig Theanderمشاهده پروفایل

استاد

• Malaria Research
• Parasite/Host Interactions
• Vaccine Development
• +۳ مورد دیگر

Professor Thor Grundtvig Theander is a distinguished Professor in Parasitology and International Health at the University of Copenhagen's Department of Immunology and Microbiology. He serves as Head of the Centre for Medical Parasitology (CMP) and Deputy Head of the Department of Immunology and Microbiology. With over 338 research outputs and an h-index of 68, his work has garnered more than 16,000 citations. Dr. Theander earned his MD in 1982 and DSc in 1992, both from the University of Copenhagen, followed by physician certification in 1988. His academic journey progressed from Assistant Medical Doctor positions (1982-1988) through Clinical Research Associate (1983-1987) to Assistant/Associate Professor (1988-2004) before becoming a full Professor in 2004. Professor Theander is internationally recognized for his groundbreaking research on malaria, particularly his work on Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1). His most significant contributions include identifying VAR2CSA as the PfEMP1 responsible for placental sequestration and developing a VAR2CSA-based vaccine for placental malaria. His 2013 Nature paper on severe malaria's association with EPCR binding represents a major breakthrough in understanding malaria pathogenesis. His research portfolio demonstrates a remarkable evolution from fundamental malaria research to innovative applications in cancer diagnostics and therapeutics. The discovery that VAR2CSA binds to carbohydrates on cancer cells has opened new avenues for cancer treatment, leading to the development of several biotech companies focused on cancer therapeutics and diagnostics. KFJ-price for preclinical research (2015, 1.5 million Dkr) Honorary Professor at University of Khartoum (1998) Member of multiple international scientific advisory committees Professor Theander has secured substantial research funding totaling millions of DKK from diverse sources including the Bill & Melinda Gates Foundation, European Union, and Danish Medical Research Council. His leadership extends to international collaborations across Africa, particularly in Tanzania, Sudan, and Benin, where he has established research capacity and clinical trial infrastructure. As founder and Head of the Centre for Medical Parasitology, he oversees a team of approximately 80 scientists, students, and technicians. The Centre, recognized as a 'Centre of Global Excellence in Health' by the Capital Region of Denmark in 2015, integrates malaria researchers from University of Copenhagen, Copenhagen University Hospital, and the State Serum Institute.

• Biophysics
• Cell Mechanics
• Optical Tweezers
• +۴ مورد دیگر

Younes Farhangibarooji is an Academic Staff member at the Biocomplexity section of the Niels Bohr Institute, University of Copenhagen. His research focuses on the intersection of biophysics, cell mechanics, and optical manipulation techniques, with significant contributions to understanding cellular structures and developing biomedical applications. His research interests span multiple cutting-edge areas in biophysics. Primary focus areas include: Actin cytoskeleton dynamics and cellular mechanics Optical tweezers technology and applications Viscoelastic properties of biological materials Nanoparticle delivery systems for cancer therapy Organoid development and morphogenesis mechanics His work combines experimental biophysics with computational analysis to unravel fundamental cellular processes. His publication record shows significant collaborative work, particularly with the research group of Professor Lene B. Oddershede. Notable contributions include the comprehensive Roadmap for optical tweezers published in Journal of Physics-Photonics (2023) and groundbreaking research on filopodia mechanics published in Nature Communications (2022). His work has garnered substantial attention, with multiple publications covered by news outlets and academic social media platforms. Dr. Farhangibarooji's research demonstrates strong interdisciplinary connections between physics, biology, and medical applications, particularly in cancer research and regenerative medicine approaches using organoid models.

• Structural Biology
• Protein Production
• NMR Spectroscopy
• +۵ مورد دیگر

Robert Dagil is an Assistant Professor in the Department of Immunology and Microbiology at the University of Copenhagen's Faculty of Health and Medical Sciences. He is a member of the VAR2CSA research team and maintains an active research profile with numerous recent publications in high-impact journals. Education: Ph.D in Structural Biology and NMR Laboratory, Department of Biology, University of Copenhagen (2013) M.Sc. in Chemistry, Department of Chemistry, University of Copenhagen (2008) Dr. Dagil's research focuses on protein structure-function relationships, with particular expertise in NMR spectroscopy, crystallography, and protein production techniques. His work has evolved from fundamental structural biology to translational applications in both infectious disease and oncology. He specializes in protein production, conjugation experiments, and development of upstream/downstream processes for recombinant proteins. His recent work demonstrates a significant shift toward cancer immunotherapy, particularly targeting oncofetal chondroitin sulfate for tumor detection and therapy development. Analysis of his recent publications (2023-2025) reveals a strong emphasis on developing novel cancer therapies through antibody targeting of specific glycosaminoglycans. His work spans multiple high-impact areas including multi-cancer detection methods, CAR T-cell therapies, bispecific T-cell engagers, and tumor-agnostic therapeutic approaches. While maintaining connections to infectious disease research (particularly malaria and SARS-CoV-2), his primary focus has shifted toward oncology applications with several publications in Nature Communications, The Lancet Microbe, and other prestigious journals. Dr. Dagil is actively involved in multiple collaborative research projects, particularly within the VAR2CSA team at the University of Copenhagen, where he contributes expertise in protein production and structural analysis. His work bridges fundamental protein science with clinical applications, demonstrating a strong translational research approach.

Ariadna Verdaguer Ferrerمشاهده پروفایل

پژوهشگر

• Analytical Chemistry
• Applied Chemistry
• Bioanalytical Chemistry
• +۴ مورد دیگر

Ariadna Verdaguer Ferrer is a Researcher at the Universitat Ramon Llull , affiliated with the IQS School of Engineering in the Department of Analytical and Applied Chemistry . Her work focuses on electrochemical sensors , bioanalytical chemistry , and proton-conducting materials . Projects : Actively involved in fusion reactor sensor development ( ECSENFUS ) and cancer detection via extracellular vesicles ( ICP-MS analysis ). Research Trends : Combines Nanotechnology and Materials Science to advance hydrogen sensors and nanotheranostics . Labs & Teams : Collaborates with the Electroquímica i bioanàlisi research group and multidisciplinary teams in Advanced Science and Ceramics International projects.

Christopher Rodellمشاهده پروفایل

استادیار

• Biomaterials
• Drug Delivery
• Supramolecular Chemistry
• +۳ مورد دیگر

Christopher Rodell, PhD, is an Assistant Professor in the School of Biomedical Engineering, Science and Health Systems at Drexel University. He leads the Tissue Instructive Materials Laboratory focusing on biomaterial design for therapeutic applications. His research integrates supramolecular chemistry, drug delivery, and immune engineering to develop novel therapies for cancer, cardiovascular disease, and organ injury. Education: Postdoctoral Scholar: Massachusetts General Hospital & Harvard Medical School (2016-2019) PhD in Bioengineering: University of Pennsylvania (2016) MS in Biomedical Engineering: Tulane University (2011) BS in Biomedical Engineering & Physics: Tulane University (2011) Research Focus: Dr. Rodell's work centers on creating injectable biomaterials (hydrogels, nanoparticles) for precision drug delivery and immune modulation. Key therapeutic areas include cancer immunotherapy (reprogramming tumor-associated macrophages), myocardial repair (hydrogel-based ventricular support), and renal disease management (targeted anti-inflammatory delivery). His research bridges fundamental material science with translational applications. Publications & Impact: With over 30 peer-reviewed articles and continuous output through 2025, his work demonstrates strong emphasis on nanoparticle-hydrogel hybrid systems for immunotherapy. Recent publications show growing focus on macrophage-targeted cancer therapies and advanced biomaterial characterization techniques. Key journals include Nature Biomedical Engineering , Advanced Materials , and Bioconjugate Chemistry . Awards & Honors: Materials Research Society Gold Award Solomon R. Pollack Award for Excellence in Graduate Research American Heart Association Predoctoral Fellowship Intellectual Property: Holds 3 patents including stabilized shear-thinning hydrogels (US Patent 9,827,321) and macrophage-targeted immunotherapeutics (patent pending).

Jed Macoskoمشاهده پروفایل

استادیار

• Biophysics
• Molecular Motors
• Cancer Mechanics
• +۵ مورد دیگر

Jed Macosko is an Assistant Professor of Physics at Wake Forest University, leading the Macosko-Holzwarth laboratory. His research spans biophysics, cancer mechanics, and educational technology development, with significant external funding securing his lab's operations. His academic journey began with a BS from the Massachusetts Institute of Technology, followed by a PhD from the University of California, Berkeley. He completed postdoctoral research under Prof. Carlos Bustamante (Howard Hughes Medical Investigator) and Prof. David Keller, and later collaborated with Nobel laureate Kary Mullis at a biotech startup. Macosko's research focuses on the load-dependence of molecular motors (particularly kinesin-1), cooperative motor behavior in cargo transport, and mechanical properties of cancer cells. His lab develops advanced methods to measure intracellular viscoelastic moduli using GFP-labeled peroxisome tracking and has created computational models like hidden Markov variational Bayes systems for particle track analysis. He actively investigates cancer cell migration through extracellular matrices and develops 3D collagen environments with stiffness gradients. His lab maintains extensive collaborations with Profs. Keith Bonin and Martin Guthold on drug discovery platforms, and with Dr. A. Daniel Johnson on educational technologies for teaching big data and virtual reality. Current funding supports projects involving undergraduate researchers studying collagen gels and cell migration mechanics. The Macosko-Holzwarth lab operates as an interdisciplinary team including PhD candidates, undergraduate researchers, and cross-departmental collaborators. They maintain active partnerships with Biology and Engineering departments while developing biotech applications from their patented research on cellular mechanics.

• Immunology
• Vaccinology
• Malaria Research
• +۴ مورد دیگر

Cyrielle Elyette Fougeroux serves as a Postdoctoral Researcher at the Department of Immunology and Microbiology within the Faculty of Health and Medical Sciences at the University of Copenhagen. Her research focuses on adenovirus vaccine platforms, malaria immunization strategies, and novel adjuvant development. She maintains active collaborations with international institutions including University Medical Center Freiburg, Sirion Biotech, and GSK, with her work on cVLP-based vaccines leading to patent development. Education: PhD in Immunology and Infectious Diseases (2014-2017), Center for Medical Parasitology, University of Copenhagen Master in Immunology (2011-2013), Pasteur Institute Immunology Advanced Program, Paris Bachelor in Physiology, Cellular and Molecular Biology (2009-2011), Paris Dr. Fougeroux's research centers on molecular mechanisms of immune responses against extracellular pathogens, with emphasis on adenovirus vectors for malaria vaccination and novel adjuvant systems. Her work bridges basic immunology and translational vaccine development, particularly investigating the EPCR-binding domains of PfEMP1 for malaria and capsid virus-like particles for SARS-CoV-2 and cancer applications. She has developed freeze-drying techniques enabling ambient-temperature vaccine storage, addressing critical distribution challenges in resource-limited settings. Analysis of her 17 publications reveals strong focus on capsid virus-like particle platforms across multiple disease targets. Her work demonstrates consistent innovation in vaccine vector design, with recent expansion into therapeutic cancer vaccines. The research shows progression from basic vector development (2022) to clinical translation (2023 Lancet Microbe paper) and novel applications in oncology (2025 publication), maintaining strong emphasis on molecular immunology mechanisms throughout. Scientific Recognition: Award for best presentation at Young Researcher Forum, Eurovaccine Conference, Paris Dr. Fougeroux actively supervises early-career researchers, having mentored 2 lab technician trainees, 1 medical student, 2 master's students, and 1 bachelor's student during her postdoctoral tenure. She manages laboratory operations including weekly group meetings, database creation, and standard operating protocols. Her international collaborations span Danish, German, and French institutions, with notable partnerships including the COUGH-1 trial study group and University Medical Center Freiburg. Current research includes adenovirus vaccine strategies, adjuvant development for extracellular pathogens, and malaria vaccine requirements evaluation.

Tyler Engstromمشاهده پروفایل

استادیار

• Soft Matter Physics
• Biological Physics
• Biomechanics
• +۷ مورد دیگر

Tyler Engstrom is an Assistant Professor in the Department of Physics and Astronomy within the College of Natural and Health Sciences at the University of Northern Colorado, where he also serves as Faculty Associate to the Dean for Internships. His academic journey spans industry and academia with roles at MiTeGen, Hobart and William Smith Colleges, and Syracuse University. His educational background: Ph.D. in Physics, Penn State University (2015) B.S. in Metallurgical Engineering, South Dakota School of Mines and Technology (2005) Dr. Engstrom's research centers on mechanical instabilities in biological systems, investigating how differential growth creates structures like brain folds and retinal foveae. His work uniquely bridges theoretical physics and biological phenomena , exploring quantum-classical analogies in elasticity while collaborating with biologists. Recent publications reveal strong focus on morphogenesis mechanisms and biomechanical modeling , with applications in developmental biology and tissue engineering. His publication record shows increasing specialization in biological physics since 2016, with significant contributions to understanding compression stiffening in tissues and quantum-inspired mechanical models. The 2023 Physical Review E paper exemplifies his innovative approach to connecting classical elasticity with quantum systems. Research funding achievements: National Eye Institute grant R15EY035473 (2024) as co-PI College of Natural and Health Sciences GRIP Awards (2023, 2024) UNC New Project Proposal grant (2021) Dr. Engstrom maintains active collaborations with biologists while mentoring students through research projects. His editorial work for American Journal of Physics demonstrates commitment to physics education. The combination of industry experience (MiTeGen), academic research, and teaching creates a dynamic environment for student involvement in cutting-edge biophysics. Though no formal lab name is specified, his research group employs interdisciplinary methods to study mechanical instabilities in biological contexts, utilizing computational modeling, theoretical frameworks, and experimental collaborations to advance understanding of tissue morphogenesis.